剰余金の配当(中間配当)、資本剰余金(IFRS)、未収収益他3件
- 【期間】
年度 | 剰余金の配当(中間配当) | 資本剰余金(IFRS) | 未収収益 | Retirement Of Treasury StockNA | Provision Of Reserve For Advanced Depreciation Of Noncurrent AssetsRE | 減損損失 - 医薬 |
---|
2007/12 | - | - | - | - | - | - |
2008/12 | - | - | - | - | - | - |
2009/12 | - | - | - | - | - | - |
2010/12 | - | - | 47.9億 | - | - | - |
2011/12 | -130億 | - | 30.2億 -36.9% | - | - | - |
2012/12 | -130億 赤縮 | - | 31.7億 +4.9% | - | - | - |
2013/12 | - | - | 4.53億 -85.7% | - | - | - |
2014/12 | - | - | - | - | - | - |
2015/12 | - | - | - | - | - | - |
2016/12 | - | - | - | - | - | - |
2017/12 | - | - | - | - | - | - |
2018/12 | - | 22.4億 | - | - | - | 9.52億 |
2019/12 | - | 249億 大幅増 | - | - | - | 63.9億 +571.6% |
2020/12 | - | 249億 +0.4% | - | - | - | 28.6億 -55.3% |
2021/12 | - | 251億 +0.7% | - | - | - | 52.9億 +85% |
2022/12 | - | 255億 +1.7% | - | - | - | 180億 +240.1% |
2023/12 | - | 212億 -17.1% | - | - | - | 108億 -39.7% |